We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitlePhase 2 safety trial targeting amyloid beta production with a gamma-secretase inhibitor in Alzheimer disease.AuthorsFleisher AS; Raman R; Siemers ER; Becerra L; Clark CM; Dean RA; Farlow MR; Galvin JE; Peskind ER; Quinn JF; Sherzai A; Sowell BB; Aisen PS; Thal LJPublicationArchives of neurology, 2008, Vol 65, Issue 8, p1031ISSN1538-3687Publication typearticleDOI10.1001/archneur.65.8.1031